Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026

STOUGHTON, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL) today announced that it will report fourth quarter and full-year 2025 financial results before the...

COLL : 45.00 (-0.40%)
1 Profitable Stock on Our Watchlist and 2 That Underwhelm

1 Profitable Stock on Our Watchlist and 2 That Underwhelm

CHE : 475.41 (+0.70%)
COLL : 45.00 (-0.40%)
TOST : 27.07 (-2.06%)
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference

STOUGHTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have four poster presentations highlighting real-world data from its ADHD product,...

COLL : 45.00 (-0.40%)
3 Small-Cap Stocks We’re Skeptical Of

3 Small-Cap Stocks We’re Skeptical Of

COLL : 45.00 (-0.40%)
GES : 16.81 (-0.30%)
TKR : 108.16 (+0.98%)
Collegium Provides 2026 Financial Guidance and Business Update

– Product Revenues, Net Expected in the Range of $805 Million to $825 Million – – Jornay PM ® Net Revenue Expected in the Range of $190 Million to $200 Million – – Adjusted EBITDA*...

COLL : 45.00 (-0.40%)
3 Russell 2000 Stocks Walking a Fine Line

3 Russell 2000 Stocks Walking a Fine Line

COLL : 45.00 (-0.40%)
CVGW : 26.45 (-0.23%)
HCAT : 1.7900 (-3.76%)
Collegium Announces the Closing of $980 Million Syndicated Credit Facility

STOUGHTON, Mass., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), today announced the closing of its inaugural syndicated credit facility. The new aggregate $980 million...

COLL : 45.00 (-0.40%)
2 Reasons to Avoid COLL and 1 Stock to Buy Instead

2 Reasons to Avoid COLL and 1 Stock to Buy Instead

COLL : 45.00 (-0.40%)
3 Cash-Producing Stocks We Think Twice About

3 Cash-Producing Stocks We Think Twice About

COLL : 45.00 (-0.40%)
ROCK : 52.79 (-0.68%)
FUBO : 1.2400 (-2.36%)
3 Unpopular Stocks We Find Risky

3 Unpopular Stocks We Find Risky

FCN : 161.62 (-0.38%)
COLL : 45.00 (-0.40%)
BK : 118.19 (+0.03%)

Barchart Exclusives

NVDA Earnings, Tariffs and Other Key Things to Watch this Week
Markets enter a critical week dominated by Wednesday's Nvidia earnings and escalating geopolitical tensions as rising U.S.-Iran hostilities push oil prices higher. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar